Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 1-8 of 8 (Search time: 0.003 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2014Comparison of peripherally inserted central venous catheters (PICC) versus subcutaneously implanted port-chamber catheters by complication and cost for patients receiving chemotherapy for non-haematological malignanciesPatel, G.; Jain, K.; Kumar, R.; Strickland, A.; Pellegrini, L.; Slavotinek, J.; Eaton, M.; McLeay, W.; Price, T.; Ullah, S.; Koczwara, B.; Kichenadasse, G.; Karapetis, C.
2014The relationship between rash, tumour KRAS mutation status and clinical and quality of life outcomes in patients with advanced colorectal cancer treated with cetuximab in the NCIC CTG/AGITG CO.17Sommeijer, D.; Karapetis, C.; Zalcberg, J.; Tu, D.; Jonker, D.; Simes, J.; Tebbutt, N.; Yip, D.; Price, T.; O'Callaghan, C.
2014Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancerJonker, D.; Karapetis, C.; Harbison, C.; O'Callaghan, C.; Tu, D.; Simes, R.; Malone, D.; Langer, C.; Tebbutt, N.; Price, T.; Shapiro, J.; Siu, L.; Wong, R.; Bjarnason, G.; Moore, M.; Zalcberg, J.; Khambata-Ford, S.
2014The role of biological therapy in metastatic colorectal cancer after first-line treatment: a meta-analysis of randomised trialsSegelov, E.; Chan, D.; Shapiro, J.; Price, T.; Karapetis, C.; Tebbutt, N.; Pavlakis, N.
2014Current opinion on optimal systemic treatment for metastatic colorectal cancer: outcome of the ACTG/AGITG expert meeting ECCO 2013Price, T.; Segelov, E.; Burge, M.; Haller, D.; Tebbutt, N.; Karapetis, C.; Punt, C.; Pavlakis, N.; Arnold, D.; Gibbs, P.; Shapiro, J.
2014Equivalence of outcomes for rural and metropolitan patients with metastatic colorectal cancer in South AustraliaHocking, C.; Broadbridge, V.; Karapetis, C.; Beeke, C.; Padbury, R.; Maddern, G.; Roder, D.; Price, T.
2014Colorectal cancer survival: an analysis of patients with metastatic disease synchronous and metachronous with the primary tumorKumar, R.; Price, T.; Beeke, C.; Jain, K.; Patel, G.; Padbury, R.; Young, G.; Roder, D.; Townsend, A.; Bishnoi, S.; Karapetis, C.
2014Final results of Australasian Gastrointestinal Trials Group ARCTIC study: an audit of raltitrexed for patients with cardiac toxicity induced by fluoropyrimidinesRansom, D.; Wilson, K.; Fournier, M.; Simes, R.; Gebski, V.; Yip, D.; Tebbutt, N.; Karapetis, C.; Ferry, D.; Gordon, S.; Price, T.